Showing 2581-2590 of 3684 results for "".
- Halozyme Appoints Jean-Pierre Bizzari, MD to Board Of Directorshttps://practicaldermatology.com/news/halozyme-appoints-jean-pierre-bizzari-md-to-board-of-directors/2459021/Halozyme Therapeutics, Inc. appointed of Jean-Pierre Bizzari, MD to its Board of Directors. Dr. Bizzari brings extensive experience in oncology drug development. "I am delighted to welcome Jean-Pierre to our Board of Directors," said Dr. Helen Torley, President and Chief Executi
- Zein Obagi, MD To Direct 24th Ultimate Skin Health Symposiumhttps://practicaldermatology.com/news/20120807-zein_obagi_md_to_direct_24th_ultimate_skin_health_symposium/2459755/Zein E. Obagi, MD was named director of the 24th Ultimate Skin Health Symposium, a three-day skin rejuvenation program taking place at the Montage Hotel, Beverly Hills, CA, from November 9-11, 2012. Key topics of the symposium will i
- Phase I Trial for Implantable Melanoma Vaccine Beginshttps://practicaldermatology.com/news/20130910-phase_i_trial_for_implantable_melanoma_vaccine_begins/2459466/
- Biosimilar Update: Dr. Reddy’s Completes Phase I Study of Proposed Tocilizumab Biosimilarhttps://practicaldermatology.com/news/biosimilar-update-dr-reddys-completes-phase-i-study-of-proposed-tocilizumab-biosimilar/2461765/Dr. Reddy’s Laboratories’ tocilizumab biosimilar candidate, DRL_TC, met its primary and secondary endpoints in a Phase I study. The company is now initiating a global Phase III study with the aim of comparing the efficacy, safety, tolerability and immunogeni
- Kintor Pharma Completes Enrollment and Dosing in Phase I Clinical Trial of AGA, Acne Drughttps://practicaldermatology.com/news/kintor-pharma-completes-enrollment-and-dosing-in-phase-i-clinical-trial-of-aga-acne-drug/2461404/Kintor Pharmaceutical Limited has completed the enrollment and dosing of 120 subjects for its U.S. phase I clinical trial of GT20029 for the treatment of androgenetic alopecia (AGA) and acne. Developed through Kintor Pharma's proprietary Proteolysis Targeting Chimera (PROTAC) platfo
- Kintor Doses First Group of Acne Patients in Phase I/II Clinical Trial of Pyrilutamidehttps://practicaldermatology.com/news/kintor-doses-first-group-of-acne-patients-in-phase-iii-clinical-trial-of-pyrilutamide/2460752/Kintor Pharmaceutical Limited successfully dosed the first group of patients in the clinical trial of Pyrilutamide as a treatment for the acne vulgaris. The Phase I/II clinical trial in China is a randomized, double-blind, placebo-controlled clinical study to evalu
- Omar A. Ibrahimi, MD, PhD, Wins ASDS Award for Outstanding Servicehttps://practicaldermatology.com/news/omar-a-ibrahimi-md-phd-wins-asds-award-for-outstanding-service/2458022/Omar A. Ibrahimi, MD, PhD, of Stamford, Connecticut, took home the 2017
- Gary D. Monheit, MD Wins Top ASDS Honorhttps://practicaldermatology.com/news/gary-d-monheit-md-wins-top-asds-honor/2459040/Gary D. Monheit, MD is the “very honored” 2014 recipient of the American Society for Dermatologic Surgery's highest honor: the Samuel J. Stegman, MD, Award for D
- Remembering a Legend: Vic A Narurkar, MDhttps://practicaldermatology.com/news/remembering-a-legend-vic-a-narurkar-md/2459921/The dermatology community lost a true rock star with the sudden passing of Vic A Narurkar MD, FAAD in late January. Loved by so many, Dr. Narurkar was the Founder of the Bay Area Laser Institute in San Francisco and a past president of the American Society of Cosmetic Derma
- Jean Bolognia, MD Honored with AAD Gold Medalhttps://practicaldermatology.com/news/jean-bolognia-md-honored-with-aad-gold-medal/2459966/During the 2019 Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C., the AAD awarded Jean Bolognia, MD, Professor of Dermatology at the Yale University School of Medicine, with its Gol